Treatment of multiple sclerosis with interferon β
- 30 September 1999
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 53 (8) , 344-350
- https://doi.org/10.1016/s0753-3322(99)80105-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Correlation of the Appearance of Anti-Interferon Antibodies During Treatment and Diminution of Efficacy: Summary of an International Workshop on Anti-Interferon AntibodiesJournal of Interferon & Cytokine Research, 1998
- Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administrationEuropean Journal of Neurology, 1998
- Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1bNeurology, 1996
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosisAnnals of Neurology, 1995
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- SPECT, MRI and cognitive functions in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983